The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Aciclovir Azevedos 250 mg Powder for solution for infusion

Laboratórios Azevedos - Indústria Farmacêutica S.APA1852/003/001

Main Information

Trade NameAciclovir Azevedos 250 mg Powder for solution for infusion
Active SubstancesAciclovir sodium
Dosage FormPowder for solution for infusion
Licence HolderLaboratórios Azevedos - Indústria Farmacêutica S.A
Licence NumberPA1852/003/001

Group Information

ATC CodeJ05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors
J05AB01 aciclovir


License statusAuthorised
Licence Issued06/10/2017
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back